Arkema will therefore be able to finalize the study of a reorganization of the chlorochemicals and hydrogen peroxide activities on the Jarrie site. This project aims to reduce very significantly exposure to risk of the local population as part of the implementation of a Plan de Prévention des Risques Technologiques (PPRT – Technological Risk Prevention Plan) through a number of measures designed to minimize risk at source. Consequently, the future industrial viability of the Arkema site and of nearby manufacturers with whom it has dealings would be boosted.
This project entails in particular the substitution of the mercury cell chlorine production process by a membrane process in line with the latest best available technology.
Arkema is working on a multi-phase industrial organization project that will involve investments the precise amount of which is currently being finalized. The project’s various stages will also include one or more authorization procedures to operate the plant, as required by environmentally classified facilities.
The project, which could not have materialized without the excellent cooperation between public authorities, local communities and our partners on the Jarrie site, will shortly be presented in detail to the personnel representative bodies.
A global chemical company and France’s leading chemicals producer, Arkema is building the future of the chemical industry every day. Deploying a responsible, innovation-based approach, we produce state-of-the-art specialty chemicals that provide customers with practical solutions to such challenges as climate change, access to drinking water, the future of energy, fossil fuel preservation and the need for lighter materials. With operations in more than 40 countries, 14,000 employees and 8 research centers, Arkema generates annual revenue of €5.9 billion and holds leadership positions in all its markets with a portfolio of internationally recognized brands. The world is our inspiration.